Encompass Health Corp (AMEX:EHC) has received a consensus recommendation of “Buy” from the nineteen analysts that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and fifteen have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $85.22.
Several equities research analysts recently commented on the company. UBS Group increased their price target on Encompass Health from $95.00 to $96.00 and gave the company a “buy” rating in a report on Friday, March 6th. Credit Suisse Group increased their price target on Encompass Health from $77.00 to $89.00 and gave the company an “outperform” rating in a report on Wednesday, January 15th. Deutsche Bank increased their price target on Encompass Health from $73.00 to $83.00 and gave the company a “hold” rating in a report on Friday, March 6th. Wells Fargo & Co cut Encompass Health from a “market perform” rating to an “underperform” rating and set a $68.00 price target for the company. in a report on Wednesday, December 11th. Finally, Robert W. Baird increased their price target on Encompass Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, March 5th.
In other news, Director Donald L. Correll sold 2,000 shares of the firm’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $59.04, for a total transaction of $118,080.00. Following the completion of the transaction, the director now directly owns 70,568 shares in the company, valued at $4,166,334.72. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.60% of the company’s stock.
Encompass Health (AMEX:EHC) last announced its earnings results on Thursday, February 6th. The company reported $0.85 EPS for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.02). The business had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.18 billion. During the same period in the prior year, the firm earned $0.80 earnings per share. Encompass Health’s revenue was up 8.1% on a year-over-year basis.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st will be given a $0.28 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $1.12 annualized dividend and a yield of ∞.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Featured Article: Quiet Period
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.